These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 12821934)
1. Role of the p38 MAPK pathway in cisplatin-based therapy. Hernández Losa J; Parada Cobo C; Guinea Viniegra J; Sánchez-Arevalo Lobo VJ; Ramón y Cajal S; Sánchez-Prieto R Oncogene; 2003 Jun; 22(26):3998-4006. PubMed ID: 12821934 [TBL] [Abstract][Full Text] [Related]
2. Activation of p38 mitogen-activated protein kinase by PYK2/related adhesion focal tyrosine kinase-dependent mechanism. Pandey P; Avraham S; Kumar S; Nakazawa A; Place A; Ghanem L; Rana A; Kumar V; Majumder PK; Avraham H; Davis RJ; Kharbanda S J Biol Chem; 1999 Apr; 274(15):10140-4. PubMed ID: 10187797 [TBL] [Abstract][Full Text] [Related]
3. MKK6/3 and p38 MAPK pathway activation is not necessary for insulin-induced glucose uptake but regulates glucose transporter expression. Fujishiro M; Gotoh Y; Katagiri H; Sakoda H; Ogihara T; Anai M; Onishi Y; Ono H; Funaki M; Inukai K; Fukushima Y; Kikuchi M; Oka Y; Asano T J Biol Chem; 2001 Jun; 276(23):19800-6. PubMed ID: 11279172 [TBL] [Abstract][Full Text] [Related]
4. Ras participates in the activation of p38 MAPK by interleukin-1 by associating with IRAK, IRAK2, TRAF6, and TAK-1. McDermott EP; O'Neill LA J Biol Chem; 2002 Mar; 277(10):7808-15. PubMed ID: 11744690 [TBL] [Abstract][Full Text] [Related]
5. Insulin activates p38 mitogen-activated protein (MAP) kinase via a MAP kinase kinase (MKK) 3/MKK 6 pathway in vascular smooth muscle cells. Igarashi M; Yamaguchi H; Hirata A; Daimon M; Tominaga M; Kato T Eur J Clin Invest; 2000 Aug; 30(8):668-77. PubMed ID: 10964158 [TBL] [Abstract][Full Text] [Related]
6. Promyelocytic leukemia is a direct inhibitor of SAPK2/p38 mitogen-activated protein kinase. Shin J; Park B; Cho S; Lee S; Kim Y; Lee SO; Cho K; Lee S; Jin BS; Ahn JH; Choi EJ; Ahn K J Biol Chem; 2004 Sep; 279(39):40994-1003. PubMed ID: 15273249 [TBL] [Abstract][Full Text] [Related]
7. Diverse mechanisms of myocardial p38 mitogen-activated protein kinase activation: evidence for MKK-independent activation by a TAB1-associated mechanism contributing to injury during myocardial ischemia. Tanno M; Bassi R; Gorog DA; Saurin AT; Jiang J; Heads RJ; Martin JL; Davis RJ; Flavell RA; Marber MS Circ Res; 2003 Aug; 93(3):254-61. PubMed ID: 12829618 [TBL] [Abstract][Full Text] [Related]
8. Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6. Enslen H; Raingeaud J; Davis RJ J Biol Chem; 1998 Jan; 273(3):1741-8. PubMed ID: 9430721 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of the p38 mitogen-activated protein kinase by SB 203580 blocks PMA-induced Mr 92,000 type IV collagenase secretion and in vitro invasion. Simon C; Goepfert H; Boyd D Cancer Res; 1998 Mar; 58(6):1135-9. PubMed ID: 9515796 [TBL] [Abstract][Full Text] [Related]
10. MEK kinase 3 directly activates MKK6 and MKK7, specific activators of the p38 and c-Jun NH2-terminal kinases. Deacon K; Blank JL J Biol Chem; 1999 Jun; 274(23):16604-10. PubMed ID: 10347227 [TBL] [Abstract][Full Text] [Related]
11. Regulation of mediator secretion in human basophils by p38 mitogen-activated protein kinase: phosphorylation is sensitive to the effects of phosphatidylinositol 3-kinase inhibitors and calcium mobilization. Gibbs BF; Plath KE; Wolff HH; Grabbe J J Leukoc Biol; 2002 Aug; 72(2):391-400. PubMed ID: 12149431 [TBL] [Abstract][Full Text] [Related]
12. Cell-type-specific activation of p38 protein kinase cascades by the novel tumor promoter palytoxin. Li S; Wattenberg EV Toxicol Appl Pharmacol; 1999 Oct; 160(2):109-19. PubMed ID: 10527909 [TBL] [Abstract][Full Text] [Related]
14. Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells. Mansouri A; Ridgway LD; Korapati AL; Zhang Q; Tian L; Wang Y; Siddik ZH; Mills GB; Claret FX J Biol Chem; 2003 May; 278(21):19245-56. PubMed ID: 12637505 [TBL] [Abstract][Full Text] [Related]
15. Requirement of mitogen-activated protein kinase kinase 3 (MKK3) for activation of p38alpha and p38delta MAPK isoforms by TGF-beta 1 in murine mesangial cells. Wang L; Ma R; Flavell RA; Choi ME J Biol Chem; 2002 Dec; 277(49):47257-62. PubMed ID: 12374793 [TBL] [Abstract][Full Text] [Related]
16. Balance between MKK6 and MKK3 mediates p38 MAPK associated resistance to cisplatin in NSCLC. Galan-Moya EM; de la Cruz-Morcillo MA; Llanos Valero M; Callejas-Valera JL; Melgar-Rojas P; Hernadez Losa J; Salcedo M; Fernández-Aramburo A; Ramon y Cajal S; Sánchez-Prieto R PLoS One; 2011; 6(12):e28406. PubMed ID: 22164285 [TBL] [Abstract][Full Text] [Related]
17. Enhanced ROS production in oncogenically transformed cells potentiates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase activation and sensitization to genotoxic stress. Benhar M; Dalyot I; Engelberg D; Levitzki A Mol Cell Biol; 2001 Oct; 21(20):6913-26. PubMed ID: 11564875 [TBL] [Abstract][Full Text] [Related]
18. c-Myc potentiates the mitochondrial pathway of apoptosis by acting upstream of apoptosis signal-regulating kinase 1 (Ask1) in the p38 signalling cascade. Desbiens KM; Deschesnes RG; Labrie MM; Desfossés Y; Lambert H; Landry J; Bellmann K Biochem J; 2003 Jun; 372(Pt 2):631-41. PubMed ID: 12646044 [TBL] [Abstract][Full Text] [Related]
19. Activation of the mitogen-activated protein kinase p38 by human cytomegalovirus infection through two distinct pathways: a novel mechanism for activation of p38. Johnson RA; Huong SM; Huang ES J Virol; 2000 Feb; 74(3):1158-67. PubMed ID: 10627526 [TBL] [Abstract][Full Text] [Related]
20. Developmental regulation of mitogen-activated protein kinase-activated kinases-2 and -3 (MAPKAPK-2/-3) in vivo during corpus luteum formation in the rat. Maizels ET; Mukherjee A; Sithanandam G; Peters CA; Cottom J; Mayo KE; Hunzicker-Dunn M Mol Endocrinol; 2001 May; 15(5):716-33. PubMed ID: 11328854 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]